Skip to navigation Skip to content

Non-infectious uveitis (NIU) Program in Pharmaceutical Benefits Scheme (PBS) 012-24070415

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised adalimumab for patients with non-infectious uveitis (NIU).

NIU and listing dates

NIU is a condition where there is inflammation inside the eye and it may result in vision loss.

Listing date: adalimumab - 1 August 2024.

See Written Authority Required Drugs, for more details.

Enquiries

Transfer enquiries about prescription arrangements to PBS Complex Drugs Programs and choose the option relevant to the condition treated.

The Resources page contains:

  • application forms
  • contact details
  • restriction and item codes
  • the PBS schedule
  • Services Australia website link
  • FAQs from Service Officers

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)

Processing an existing Authority request in the Pharmaceutical Benefits Scheme (PBS)

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Written Authority Required Drugs

Processing Delayed Assessment requests in the Pharmaceutical Benefits Scheme (PBS)

Processing new Authority requests in the Pharmaceutical Benefits Scheme (PBS)